| Literature DB >> 26086742 |
Tingting Wu1, Yi Liu2, Zhipeng Fan3, Junji Xu1, Luyuan Jin1, Zhenhua Gao1, Zhifang Wu1, Lei Hu1, Jinsong Wang1, Chunmei Zhang1, Wanjun Chen4, Songlin Wang1,5.
Abstract
microRNAs (miRNAs) act as regulatory signals for maintaining stemness, self-renewal, and differentiation of mesenchymal stem cells (MSCs), but whether miRNAs modulate the immunoregulatory function of MSCs remains largely unknown. Here, we show that miR-21 negatively regulates the activity of immunoregulatory cytokine transforming growth factor-β1 (TGF-β1) in MSCs. Consistently, bone marrow MSCs (BMMSCs) from miR-21(-/-) mice show enhanced immunosuppressive function by more TGF-β1 secretion and induce more CD4(+) Foxp3(+) regulatory T cells compared with wild-type BMMSCs in vitro, which anti-TGF-β1 antibody abrogates. Mechanistically, miR-21 inhibits TGF-β1 expression by targeting phosphatase and tensin homolog deleted on chromosome 10 (PTEN) in BMMSCs. Downstream of PTEN, miR-21 promotes activation of Akt, and consequently increases activation of NF-κB pathway. Importantly, adoptive transfer of miR-21(-/-) BMMSCs into mice with experimental colitis more effectively ameliorates colonic inflammation in a TGF-β1-dependent manner. Thus, these findings indicate a previously uncovered mechanism of miR-21 control immunoregulatory function of BMMSCs through TGF-β1 inhibition.Entities:
Keywords: Immunoregulation; Mesenchymal stem cells; PTEN; Transforming growth factor-β1; miR-21
Mesh:
Substances:
Year: 2015 PMID: 26086742 DOI: 10.1002/stem.2081
Source DB: PubMed Journal: Stem Cells ISSN: 1066-5099 Impact factor: 6.277